Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib in Primary Dysmenorrhea
NCT00092729Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Jun 2002
- Primary completion
- Dec 2002
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of etoricoxib in primary dysmenorrhea (PD) (3 arms), sponsored by Organon & Co. Primary endpoints: Total Pain Relief over 8 hours, Sum of Pain Intensity Difference over 8 hours and 1 more. Started Jun 2002; status: completed.
02
Drugs
etoricoxib
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on NCT00092729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092729.